Compare DeFi (DEFI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DeFi vs Enzyme — how do they compare? DeFi trades at Rp13.17 (market cap Rp19,87M, Rp6,62M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 6.8× DeFi's market cap, and DeFi's supply is capped (1,7B / 3B DEFI (59%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold DeFi for 7 Days and Enzyme for 28 Days on average.
| DEFI | MLN | |
|---|---|---|
Market Cap | Rp19,87M | Rp134,13M |
Volume (24h) | Rp6,62M | Rp104,56M |
Circulating Supply | 1,7B / 3B DEFI (59%) | 3,3M MLN |
Typical Hold Time | 7 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DEFI token currently shows limited market activity with a modest market cap of Rp19.87M and 59% circulating supply. The 7-day average hold time suggests short-term trading patterns dominate. Recent market context shows crypto volatility with Bitcoin testing key levels while regulatory developments like the Clarity Act progress. Technical indicators suggest the token operates in a narrow range with low liquidity.
Overall outlook remains cautious due to thin liquidity and minimal ecosystem developments. Key opportunity lies in potential protocol upgrades, while major risks include regulatory uncertainty and market volatility. Investors should monitor on-chain activity for signs of renewed interest.
Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.
Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.
About DeFi
DeFi is a Web3 antivirus and SocialFi super app that has been protecting users from scams and bad actors since its launch in July 2020. By 2023, the platform grew to over 5 million users, tracking $25 billion in user funds. Its DeFi Antivirus has already secured over $1.2 billion from potential losses, while providing leading portfolio-tracking and security solutions.
Read more on DEFI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
